πŸ‡ΊπŸ‡Έ FDA
Patent

US 9932589

EML4-ALK fusion gene

granted A61KA61K31/506A61P

Quick answer

US patent 9932589 (EML4-ALK fusion gene) held by CUREGENE K.K. expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CUREGENE K.K.
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/506, A61P, A61P35/00, A61P43/00